Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | KZR-261 |
| Synonyms | |
| Therapy Description |
KZR-261 inhibits Sec61, potentially leading to inhibition of tumor growth (J Clin Oncol 38, no. 15_suppl (May 20, 2020) 2515-2515). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| KZR-261 | KZR 261|KZR261 | KZR-261 inhibits Sec61, potentially leading to inhibition of tumor growth (J Clin Oncol 38, no. 15_suppl (May 20, 2020) 2515-2515). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05047536 | Phase I | KZR-261 | KZR-261 in Subjects With Advanced Solid Malignancies | Active, not recruiting | USA | 0 |